Literature DB >> 17273973

Penetrance of craniofacial anomalies in mouse models of Smith-Magenis syndrome is modified by genomic sequence surrounding Rai1: not all null alleles are alike.

Jiong Yan1, Weimin Bi, James R Lupski.   

Abstract

Craniofacial abnormality is one of the major clinical manifestations of Smith-Magenis syndrome (SMS). Previous analyses in a mixed genetic background of several SMS mouse models--including Df(11)17/+ and Df(11)17-1/+, which have 2-Mb and 590-kb deletions, respectively, and Rai1(-/+)--revealed that the penetrance of the craniofacial phenotype appears to be influenced by deletion size and genetic background. We generated an additional strain with a 1-Mb deletion intermediate in size between the two described above. Remarkably, the penetrance of its craniofacial anomalies in the mixed background was between those of Df(11)17 and Df(11)17-1. We further analyzed the deletion mutations and the Rai1(-/+) allele in a pure C57BL/6 background, to control for nonlinked modifier loci. The penetrance of the craniofacial anomalies was markedly increased for all the strains in comparison with the mixed background. Mice with Df(11)17 and Df(11)17-1 deletions had a similar penetrance, suggesting that penetrance may be less influenced by deletion size, whereas that of Rai1(-/+) mice was significantly lower than that of the deletion strains. We hypothesize that potential trans-regulatory sequence(s) or gene(s) that reside within the 590-kb genomic interval surrounding Rai1 are the major modifying genetic element(s) affecting the craniofacial penetrance. Moreover, we confirmed the influence of genetic background and different deletion sizes on the phenotype. The complicated control of the penetrance for one phenotype in SMS mouse models provides tools to elucidate molecular mechanisms for penetrance and clearly shows that a null allele caused by chromosomal deletion can have different phenotypic consequences than one caused by gene inactivation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17273973      PMCID: PMC1821110          DOI: 10.1086/512043

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  39 in total

1.  Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?

Authors:  Christopher N Vlangos; Dwight K C Yim; Sarah H Elsea
Journal:  Mol Genet Metab       Date:  2003-06       Impact factor: 4.797

2.  Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.

Authors:  J T Richtsmeier; L L Baxter; R H Reeves
Journal:  Dev Dyn       Date:  2000-02       Impact factor: 3.780

3.  Nested chromosomal deletions induced with retroviral vectors in mice.

Authors:  H Su; X Wang; A Bradley
Journal:  Nat Genet       Date:  2000-01       Impact factor: 38.330

4.  Atp11p and Atp12p are assembly factors for the F(1)-ATPase in human mitochondria.

Authors:  Z G Wang; P S White; S H Ackerman
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

5.  Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).

Authors:  Katherina Walz; Richard Paylor; Jiong Yan; Weimin Bi; James R Lupski
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

6.  Genes in a refined Smith-Magenis syndrome critical deletion interval on chromosome 17p11.2 and the syntenic region of the mouse.

Authors:  Weimin Bi; Jiong Yan; Pawe Stankiewicz; Sung-Sup Park; Katherina Walz; Cornelius F Boerkoel; Lorraine Potocki; Lisa G Shaffer; Koen Devriendt; Magorzata J M Nowaczyk; Ken Inoue; James R Lupski
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

7.  A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease.

Authors:  C Rampazzo; L Gallinaro; E Milanesi; E Frigimelica; P Reichard; V Bianchi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Genetic profile of insertion mutations in mouse leukemias and lymphomas.

Authors:  G M Hansen; D Skapura; M J Justice
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

9.  COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast.

Authors:  Jiong Yan; Katherina Walz; Hisashi Nakamura; Sandra Carattini-Rivera; Qi Zhao; Hannes Vogel; Ning Wei; Monica J Justice; Allan Bradley; James R Lupski
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Variability in clinical phenotype despite common chromosomal deletion in Smith-Magenis syndrome [del(17)(p11.2p11.2)].

Authors:  Lorraine Potocki; Christine J Shaw; Pawel Stankiewicz; James R Lupski
Journal:  Genet Med       Date:  2003 Nov-Dec       Impact factor: 8.822

View more
  19 in total

Review 1.  Yin-yang actions of histone methylation regulatory complexes in the brain.

Authors:  Patricia Marie Garay; Margarete Aryanka Wallner; Shigeki Iwase
Journal:  Epigenomics       Date:  2016-11-18       Impact factor: 4.778

Review 2.  Phenotypic impact of genomic structural variation: insights from and for human disease.

Authors:  Joachim Weischenfeldt; Orsolya Symmons; François Spitz; Jan O Korbel
Journal:  Nat Rev Genet       Date:  2013-02       Impact factor: 53.242

3.  Transient pairing of homologous Oct4 alleles accompanies the onset of embryonic stem cell differentiation.

Authors:  Megan S Hogan; David-Emlyn Parfitt; Cinthya J Zepeda-Mendoza; Michael M Shen; David L Spector
Journal:  Cell Stem Cell       Date:  2015-03-05       Impact factor: 24.633

Review 4.  Animal models of Williams syndrome.

Authors:  Lucy R Osborne
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-05-15       Impact factor: 3.908

5.  Opposing phenotypes in mice with Smith-Magenis deletion and Potocki-Lupski duplication syndromes suggest gene dosage effects on fluid consumption behavior.

Authors:  Detlef H Heck; Wenli Gu; Ying Cao; Shuhua Qi; Melanie Lacaria; James R Lupski
Journal:  Am J Med Genet A       Date:  2012-09-18       Impact factor: 2.802

6.  Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22.

Authors:  C M B Carvalho; M Bartnik; D Pehlivan; P Fang; J Shen; J R Lupski
Journal:  Clin Genet       Date:  2011-06-20       Impact factor: 4.438

7.  RAI1 Overexpression Promotes Altered Circadian Gene Expression and Dyssomnia in Potocki-Lupski Syndrome.

Authors:  Sureni V Mullegama; Joseph T Alaimo; Michael D Fountain; Brooke Burns; Amanda Hebert Balog; Li Chen; Sarah H Elsea
Journal:  J Pediatr Genet       Date:  2017-03-07

Review 8.  Copy number variation in human health, disease, and evolution.

Authors:  Feng Zhang; Wenli Gu; Matthew E Hurles; James R Lupski
Journal:  Annu Rev Genomics Hum Genet       Date:  2009       Impact factor: 8.929

9.  Circadian abnormalities in mouse models of Smith-Magenis syndrome: evidence for involvement of RAI1.

Authors:  Melanie Lacaria; Wenli Gu; James R Lupski
Journal:  Am J Med Genet A       Date:  2013-05-23       Impact factor: 2.802

10.  Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice.

Authors:  E J Young; T Lipina; E Tam; A Mandel; S J Clapcote; A R Bechard; J Chambers; H T J Mount; P J Fletcher; J C Roder; L R Osborne
Journal:  Genes Brain Behav       Date:  2007-08-03       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.